SCHEMBL5095115

SCHEMBL5095115

COc1cccc(S(=O)(=O)n2ncc3ccc(N4CCNCC4)cc32)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 12/20 0.53
HTR1A P08908 3/20 0.53
HTR2A P28223 2/20 0.53
HTR7 P34969 2/20 0.53
DRD2 P14416 1/20 0.53
ADRB1 P08588 1/20 0.53
HTR1D P28221 1/20 0.49
HTR1B P28222 1/20 0.49
CYP3A4 P08684 1/20 0.46
FGFR4 P22455 1/20 0.45
MAPT P10636 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
HTR3A P46098 1/20 0.43
TGFBR1 P36897 1/20 0.43
ACVR1 Q04771 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5103482 0.89 HTR6 (0.53) HTR6HTR1AHTR2AHTR7DRD2
SCHEMBL1537811 0.85 HTR6 (0.61) HTR6HTR1AHTR2AHTR7DRD2
SCHEMBL5103384 0.85 PKM (0.47) HTR6HTR1AHTR1DHTR1BTGFBR1
SCHEMBL5095035 0.85 HTR6 (0.53) HTR6HTR1AHTR2AHTR7DRD2
SCHEMBL5103766 0.85 HTR6 (0.54) HTR6HTR1AHTR2AHTR7DRD2
SCHEMBL5103480 0.83 KMT2A (0.56) HTR6HTR1AADRB1HTR1DHTR1B
SCHEMBL14100662 0.83 HTR6 (0.43) HTR6HTR1AHTR2AHTR7DRD2
SCHEMBL5103747 0.83 DRD3 (0.51) HTR6HTR1AHTR2AHTR7DRD2
SCHEMBL5103899 0.82 HTR6 (0.66) HTR6HTR1AHTR2AHTR7DRD2
SCHEMBL5091072 0.81 ALK (0.45) HTR6HTR1AHTR7DRD2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US claimed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
WO-2008101247-A2 6 ' SUBSTITUTED INDOLE AND INDAZOLE DERIVATIVES HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR1B, HTR1A HTR6 1/4885HTR1A 3/4885HTR2A 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.